兰州:药品流通领域将建失信“黑名单”

2017-12-22 佚名 新华网

记者21日从兰州市食品药品监督管理局获悉,从今年12月起,甘肃省兰州市首次在医药领域引入失信“黑名单”制度,要求公立医院2年内不得购入失信“黑名单”企业药品。

记者21日从兰州市食品药品监督管理局获悉,从今年12月起,甘肃省兰州市首次在医药领域引入失信“黑名单”制度,要求公立医院2年内不得购入失信“黑名单”企业药品。

据介绍,日前兰州市政府办公厅正式印发了《关于进一步改革完善药品生产流通使用政策的实施意见》,从提高药品质量疗效、整顿药品流通秩序、规范医疗和用药行为3个方面提出了18条改革措施,涉及药品生产、流通、使用各个环节。

根据意见,兰州市将严厉打击租借证照、虚假交易、伪造记录、非法渠道购销药品、商业贿赂、价格欺诈、价格垄断以及伪造、虚开发票等违法违规行为。对查实的药品违法违规失信行为的企事业单位法人和自然人建立不良信用记录,并按规定将不良信用记录信息上报至市信用信息共享与交换平台和“信用中国(甘肃兰州)”网站进行公示。

同时,建立药品流通领域失信“黑名单”制度,市场主体监管部门根据具体失信行为,将失信者列入失信“黑名单”,采取联合惩戒措施,公立医院2年内不得购入失信“黑名单”企业药品。对累犯或情节较重的,依法进一步加大处罚力度,提高违法违规成本。对辖区内监督检查情况应及时公开,对设计药品经营企业吊证、撤证的,在官网挂网公告,引导社会各方参与监督,推进食品药品领域诚信体系建设。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-24 131****2916

    不错的文章值得推荐

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-24 kalseyzl
  5. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-24 杨柳青青

    签到学习了--

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-23 虈亣靌

    如此说来还是一个好事情

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1755134, encodeId=1c371e551341f, content=<a href='/topic/show?id=2f82103280eb' target=_blank style='color:#2F92EE;'>#黑名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103280, encryptionId=2f82103280eb, topicName=黑名单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f52536838019, createdName=zhty5349, createdTime=Thu Apr 26 20:19:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080329, encodeId=22052080329c8, content=<a href='/topic/show?id=4a468e448a7' target=_blank style='color:#2F92EE;'>#药品流通#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87448, encryptionId=4a468e448a7, topicName=药品流通)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Sun Sep 09 23:19:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272225, encodeId=c6262e222501, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun Dec 24 22:44:08 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588965, encodeId=8e3015889654b, content=<a href='/topic/show?id=899d2996e09' target=_blank style='color:#2F92EE;'>#兰州#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29967, encryptionId=899d2996e09, topicName=兰州)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ab17645625, createdName=kalseyzl, createdTime=Sun Dec 24 10:19:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272074, encodeId=8d6e2e2074f2, content=签到学习了--, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eeef1960262, createdName=杨柳青青, createdTime=Sun Dec 24 09:46:42 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271837, encodeId=0b352e1837f3, content=如此说来还是一个好事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sat Dec 23 12:57:10 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271627, encodeId=64c42e162783, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Dec 22 21:47:29 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-22 thlabcde

    好资料学习了!

    0

相关资讯

东北三省一区“两票制”互认 药品流通企业将大洗牌

8月24日,吉林省医药采购中心公布《关于公示“东北三省一区”公立医疗机构药品采购“两票制”界定结果的通知》。

扒一扒,网上药店这18年经历了什么

近日,国务院办公厅发布《关于进一步改革完善药品生产流通使用政策的若干意见》(以下简称《意见》)。其中,关于“互联网+药品流通”,这样写道以满足群众安全便捷用药需求为中心,积极发挥“互联网+药品流通”在减少交易成本、提高流通效率、促进信息公开、打破垄断等方面的优势和作用。引导“互联网+药品流通”规范发展,支持药品流通企业与互联网企业加强合作,推进线上线下融合发展,培育新兴业态。规范零售药店互联网

备案制下的百万药代还有这些新出路(上篇)

从今年2月9日国务院办公厅印发《关于进一步改革完善药品生产流通使用政策的若干意见》中首先从国家层面提出要求医药代表只能从事学术推广、技术咨询等活动,不得承担药品销售任务,其失信行为记入个人信用记录的代表备案制,到上海出台的代表备案中的“三定一有”及安徽相继出台医药代表备案细则,再到十九大明确提出全面以药养医,《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》中再次重申禁止医药代表承担药品销售任

门诊药房大剥离,药品或被踢出医院!

在“进一步破除以药补医机制”环节,安徽一方面要求医院不能限制处方外流,同时表示,具备条件的可探索将门诊药房从医疗机构剥离。

不良记录药企将被公立医院“封杀”

安徽省发布《关于进一步改革完善药品生产流通使用政策的实施意见》,从药品流通、规范用药等多方面加大监管力度。

回眸2017两票制:艰难的选择 复杂的博弈

回眸2017年,称这一年是“两票制”年毫不为过。